Download Sample, Rising Demand for Wound Care Products Due to Chronic Wounds, Surgical Infections, and Aging Populations
Approximately 1 billion world population is affected by chronic wounds which become a bigger challenge, especially in developed countries where 1-2% of the population suffers from these painful conditions. Long-term health conditions such as diabetes, pressure ulcers, and vascular diseases are major causes of chronic wounds and as people age, they become more susceptible to these health conditions which raise the risk of developing chronic conditions like diabetic foot ulcers, pressure ulcers, and venous leg ulcers. According to WHO report, by 2050, the elderly population will grow massively with 80% of the older persons residing in low- and middle-income countries, while the proportion of people aged 60 years or older will approach double from the 2015 level of 12% of the global population to 22% by 2050.
There will be 1 in 6 people aged more than 60 by 2030 which has grown from 1 billion in 2020 to 1.4 billion. It is estimated that the elderly population will be 2.1 billion and increase in the population aged 80 and above by three times up to 426 million within the next couple of decades. With the growing aging population, there is a rising need for wound care products such as wound cleansers to prevent infections and encourage healing in elderly individuals.
As the global population ages, chronic conditions like diabetes are on the rise which leads to a higher incidence of chronic wounds such as Diabetic foot ulcers (DFUs) that affect 25% of individuals with diabetes over their lifetime with global annual cases ranging from 1.9 to 26.1 million. Similarly, venous leg ulcers impact 1-2% of the general population while 4% for those over 65 indicates the growing demand for effective, ongoing wound care management.
Surgical site infection (SSIs) is one of the concerning issues in healthcare, as it lengthens the hospital stays and leads to complications. Approximately, 321 million surgical procedures worldwide including both elective and essential surgeries, and the demand for effective post-operative wound care also grows to prevent infections, promote healing, and reduce complications.
As more people become aware, the need for wound care solutions increases with growing emphasis on preventing infections and effectively managing both short-term and long-term effects of SSIs. Additionally, the a surge in acute wounds caused by accidents, sports injuries, surgeries, and burns with 11 million burn incidents happening each year, requiring specialized wound treatment.
There will be 1 in 6 people aged more than 60 by 2030 which has grown from 1 billion in 2020 to 1.4 billion. It is estimated that the elderly population will be 2.1 billion and increase in the population aged 80 and above by three times up to 426 million within the next couple of decades. With the growing aging population, there is a rising need for wound care products such as wound cleansers to prevent infections and encourage healing in elderly individuals.
As the global population ages, chronic conditions like diabetes are on the rise which leads to a higher incidence of chronic wounds such as Diabetic foot ulcers (DFUs) that affect 25% of individuals with diabetes over their lifetime with global annual cases ranging from 1.9 to 26.1 million. Similarly, venous leg ulcers impact 1-2% of the general population while 4% for those over 65 indicates the growing demand for effective, ongoing wound care management.
Surgical site infection (SSIs) is one of the concerning issues in healthcare, as it lengthens the hospital stays and leads to complications. Approximately, 321 million surgical procedures worldwide including both elective and essential surgeries, and the demand for effective post-operative wound care also grows to prevent infections, promote healing, and reduce complications.
As more people become aware, the need for wound care solutions increases with growing emphasis on preventing infections and effectively managing both short-term and long-term effects of SSIs. Additionally, the a surge in acute wounds caused by accidents, sports injuries, surgeries, and burns with 11 million burn incidents happening each year, requiring specialized wound treatment.
Improving Infection Control with Wound Care Practices in Healthcare Settings and Home Healthcare Environments
Healthcare-associated infections are infections that occur in healthcare settings as a result of the delivery of medical care and have affected millions of people across the globe. According to WHO, 1 in 10 patients is affected by HAIs, and the condition is much higher in low-/middle-income countries and in high-risk patients such as those in intensive care units.
The common HAIs include surgical site infections, catheter-associated urinary tract infections, and ventilator-associated pneumonia and they are due to improper sterilization, wrong hand washing, or multi-drug resistant organisms. Infection control has great prominence in hospitals and healthcare centers where International standards are meant for its reduction attributed to the tremendous rise of awareness regarding the need for infection control along in open wounds.
Effective infection control involves strict protocols, including hand hygiene compliance, sterilization of instruments, isolation measures, and surveillance systems. Innovations in antimicrobial coatings, advanced wound care, and awareness campaigns are pivotal in reducing HAI prevalence that ensures patient safety, and minimizing healthcare costs. Consequently, WHO has implemented Infection Prevention and Control (IPC) a critical, evidence-based strategy to protect patients and health workers from avoidable infections that ensures safety and quality in healthcare. The rising awareness about infection control along with the increasing demand for wound cleansers is driven by a combination of factors including a greater focus on healthcare hygiene, innovations in wound care products, an aging population, and the need to prevent infections in both hospital and home care settings.
The home healthcare sector is booming, driven by an increasing elderly population, the prevalence of chronic illnesses, and patients' inclination for recovery at home because of affordability and ease. Around 70% of individuals using home healthcare are 65 or older, and many face chronic issues such as heart disease, diabetes, and vascular disorders, frequently resulting in hard-to-manage chronic wounds. Diabetic ulcers are frequent in older adults and require specific care because of their slow healing.
With the rise of home care, there is a growing need for efficient, easy-to-use wound care items such as sprays, gels, and foams that facilitate simple and comfortable self-treatment as these instruments enable patients to take charge of their recovery autonomously. Such a home-care setting reduces infections and lowers healthcare expenses while enhancing the overall wellness of both patients and caregivers in the changing realm of at-home medical care.
The common HAIs include surgical site infections, catheter-associated urinary tract infections, and ventilator-associated pneumonia and they are due to improper sterilization, wrong hand washing, or multi-drug resistant organisms. Infection control has great prominence in hospitals and healthcare centers where International standards are meant for its reduction attributed to the tremendous rise of awareness regarding the need for infection control along in open wounds.
Effective infection control involves strict protocols, including hand hygiene compliance, sterilization of instruments, isolation measures, and surveillance systems. Innovations in antimicrobial coatings, advanced wound care, and awareness campaigns are pivotal in reducing HAI prevalence that ensures patient safety, and minimizing healthcare costs. Consequently, WHO has implemented Infection Prevention and Control (IPC) a critical, evidence-based strategy to protect patients and health workers from avoidable infections that ensures safety and quality in healthcare. The rising awareness about infection control along with the increasing demand for wound cleansers is driven by a combination of factors including a greater focus on healthcare hygiene, innovations in wound care products, an aging population, and the need to prevent infections in both hospital and home care settings.
The home healthcare sector is booming, driven by an increasing elderly population, the prevalence of chronic illnesses, and patients' inclination for recovery at home because of affordability and ease. Around 70% of individuals using home healthcare are 65 or older, and many face chronic issues such as heart disease, diabetes, and vascular disorders, frequently resulting in hard-to-manage chronic wounds. Diabetic ulcers are frequent in older adults and require specific care because of their slow healing.
With the rise of home care, there is a growing need for efficient, easy-to-use wound care items such as sprays, gels, and foams that facilitate simple and comfortable self-treatment as these instruments enable patients to take charge of their recovery autonomously. Such a home-care setting reduces infections and lowers healthcare expenses while enhancing the overall wellness of both patients and caregivers in the changing realm of at-home medical care.
Recent Trends in the Wound Cleanser Industry:
- As the geriatric population grows, the prevalence of chronic wounds, especially in diabetic patients, is boosting demand for specialized wound cleansers
- Innovation in wound cleanser formulas is ongoing with manufacturers focusing on more effective and targeted solutions
- The convenience and patient comfort offered by wound cleanser wipes are driving significant growth
- Healthcare providers increasingly seek cleansers with antimicrobial properties to reduce infection risks in surgical wounds
- More hospitals are adopting stringent wound care protocols, emphasizing prevention to reduce surgical site infections (SSIs)
- Rising government initiatives and implemented programs to improve wound care management
- As home healthcare continues to rise, the demand for accessible and easy-to-use wound cleansers is increasing
Explore Our Breakthrough Market Segmentation and Personalize it to Meet Your Business Needs…!
The Impact of Strict Regulations and High Costs on Innovation in the Wound Care Industry
The wound cleaner market encounters considerable obstacles, primarily arising from intricate regulatory demands and the high expenses associated with product approval. Wound care products, classified as either medical devices or medications, are required to follow stringent regulations set by entities such as the U.S. FDA and EMA. These regulations require extensive clinical trials, preliminary assessments, biocompatibility studies, and toxicology evaluations to demonstrate safety and efficacy.
The financial strain of these rigorous processes, particularly the high costs linked to research and development, presents major challenges for smaller companies and results in considerable delays in launching new products into the market. Consequently, these factors hinder innovation and postpone the adoption of possibly beneficial wound care solutions.
Moreover, the FDA's proposed reclassification of certain wound care products into higher-risk categories (Class II and III) introduces additional complexities. These products would require more extensive premarket testing, including 510(k) submissions or Premarket Approval (PMA), increasing both development costs and time-to-market. Particularly, smaller manufacturers encounter difficulties in complying with these new standards, potentially hindering innovation in the wound care industry.
The growing need for antimicrobial resistance (AMR) testing and stricter safety regulations worsen these issues. As a result, the regulatory hurdles delay the introduction of new technologies and create a financial barrier, hindering innovation and limiting access to advanced wound care solutions.
The financial strain of these rigorous processes, particularly the high costs linked to research and development, presents major challenges for smaller companies and results in considerable delays in launching new products into the market. Consequently, these factors hinder innovation and postpone the adoption of possibly beneficial wound care solutions.
Moreover, the FDA's proposed reclassification of certain wound care products into higher-risk categories (Class II and III) introduces additional complexities. These products would require more extensive premarket testing, including 510(k) submissions or Premarket Approval (PMA), increasing both development costs and time-to-market. Particularly, smaller manufacturers encounter difficulties in complying with these new standards, potentially hindering innovation in the wound care industry.
The growing need for antimicrobial resistance (AMR) testing and stricter safety regulations worsen these issues. As a result, the regulatory hurdles delay the introduction of new technologies and create a financial barrier, hindering innovation and limiting access to advanced wound care solutions.
Initiatives and Industry Partnerships Shaping the Future of Wound Care and Infection Management
Government initiatives and healthcare programs focus enhancement of wound care management, leading to better patient care. Governments globally are launching initiatives to tackle the challenges in wound care, highlighting the importance of wound cleansers in preparing wound beds and managing infection risks. In March 2024, Brightshores Health System received co-investment from DIGITAL, Canada's Global Innovation Cluster, to develop an AI-powered Advanced Wound Care Network.
In partnership with Swift Medical, Giishkaandago’Ikwe Health Services, and others, the project aims to transform wound care with AI-driven assessments that enhance healing speed and improve patient outcomes. Additionally, in June 2023, The Wound Company launched with US$4.25M in seed funding from Susa Ventures and Sozo Ventures to revolutionize wound and ostomy care. The company aims to reduce amputation rates and healthcare costs by providing on-demand, expert care through telehealth and in-person visits. Their innovative approach has already shown promising results in reducing care costs and improving patient outcomes.
The emergence of strategic partnerships and innovative products in the wound care sector is significantly shaping the wound cleanser market. For instance, in October 2024, Mölnlycke partnered with Transdiagen to leverage novel wound gene signatures, advancing innovation in chronic wound care through data-driven insights and evidence-based development of biological treatment solutions.
Additionally, in November 2022, InfuSystem and Sanara MedTech formed SI Wound Care, LLC, a partnership providing advanced wound care solutions, including Cork Medical’s NPWT devices, aimed at improving outcomes, reducing costs, and enhancing satisfaction for patients and providers nationwide. Collaborations between companies focusing on advanced wound care solutions enable a more comprehensive range of products, from negative pressure wound therapy (NPWT) devices to cutting-edge antimicrobial wound irrigation systems.
These partnerships help address the growing demand for cost-effective, high-quality wound care options to improve patient outcomes and enhance healthcare providers' ability to treat both chronic and acute wounds. The introduction of non-toxic, antimicrobial wound cleansers with rapid, effective irrigation solutions further supports the industry's growth by offering safer alternatives to traditional wound care products that set new standards for clinical practice and expand treatment possibilities.
For instance, in August 2024, Biomiq Inc. launched PureCleanse™ STAT, an innovative hypochlorous acid-based wound irrigation system designed for rapid use in emergency and chronic care. Non-toxic and antimicrobial, it features QuickTab™ Technology for precision application and optimal pressure, enhancing wound care outcomes by effectively addressing biofilm and improving clinician efficiency in critical scenarios.
In partnership with Swift Medical, Giishkaandago’Ikwe Health Services, and others, the project aims to transform wound care with AI-driven assessments that enhance healing speed and improve patient outcomes. Additionally, in June 2023, The Wound Company launched with US$4.25M in seed funding from Susa Ventures and Sozo Ventures to revolutionize wound and ostomy care. The company aims to reduce amputation rates and healthcare costs by providing on-demand, expert care through telehealth and in-person visits. Their innovative approach has already shown promising results in reducing care costs and improving patient outcomes.
The emergence of strategic partnerships and innovative products in the wound care sector is significantly shaping the wound cleanser market. For instance, in October 2024, Mölnlycke partnered with Transdiagen to leverage novel wound gene signatures, advancing innovation in chronic wound care through data-driven insights and evidence-based development of biological treatment solutions.
Additionally, in November 2022, InfuSystem and Sanara MedTech formed SI Wound Care, LLC, a partnership providing advanced wound care solutions, including Cork Medical’s NPWT devices, aimed at improving outcomes, reducing costs, and enhancing satisfaction for patients and providers nationwide. Collaborations between companies focusing on advanced wound care solutions enable a more comprehensive range of products, from negative pressure wound therapy (NPWT) devices to cutting-edge antimicrobial wound irrigation systems.
These partnerships help address the growing demand for cost-effective, high-quality wound care options to improve patient outcomes and enhance healthcare providers' ability to treat both chronic and acute wounds. The introduction of non-toxic, antimicrobial wound cleansers with rapid, effective irrigation solutions further supports the industry's growth by offering safer alternatives to traditional wound care products that set new standards for clinical practice and expand treatment possibilities.
For instance, in August 2024, Biomiq Inc. launched PureCleanse™ STAT, an innovative hypochlorous acid-based wound irrigation system designed for rapid use in emergency and chronic care. Non-toxic and antimicrobial, it features QuickTab™ Technology for precision application and optimal pressure, enhancing wound care outcomes by effectively addressing biofilm and improving clinician efficiency in critical scenarios.
Know Your Competitors and Strengthen Market Share Effectively
Impact of Chronic Diseases and Healthcare Initiatives Improves Global Wound Care Management
North America is the leading region that dominates the global wound cleanser market due to high healthcare expenditure, advanced medical infrastructure, and the rising incidence of chronic conditions such as diabetes and obesity, which increase the risk of wounds and infections. Around 10.5 million Medicare recipients suffer from chronic wounds, 3% of all adults aged 65 and older are now living with open wounds, and as the population aged 65+ is expected to increase to more than 77 million in 2060, this case will certainly exacerbate.
Second, some 51.4 million inpatient surgeries annually account for more than 400,000 additional days spent in the hospital along with an added healthcare bill of almost US$900 million further, SSIs affect increasing numbers of chronic wounds and the rising prevalence of both requires improving their management and developing economical methods. Such factors lead to rising demand for wound care in this region.
In Europe, HAIs affect about 9 million HAIs occur every year in acute and long-term care facilities which lead to 25 million extra hospital days and cost EUR 13-24 billion. In Europe, effective wound care plays a crucial role in preventing HAIs, by ensuring proper wound cleansing, dressing, and management, healthcare providers minimize infection risks, promote faster healing, and reduce complications. For this reason, the government is focusing on the emphasis of wound care in this region.
For example, the UK’s 2024 Wound Care Initiative targets the increasing challenge of chronic wounds, which expense the NHS GBP 8.3 billion each year. Drawing from past achievements, the program aims to transform wound care by encouraging collaboration with healthcare leaders to boost integration and emphasize efficient care, thereby improving the quality and accessibility of treatment for patients with chronic wounds. Progressive wound care methods, including antimicrobial therapies and cutting-edge dressings, are essential for protecting patient results and lowering healthcare expenses.
The Asia-Pacific region is expected to grow at the fastest rate due to the prevalence of chronic diseases, particularly in countries like China, India, and Japan which leads to healthcare awareness and improvements healthcare system. In nations such as India, the problem is worsened by restricted healthcare availability, poor levels of education, and financial obstacles, which lead to delays in treatment and make wound care issues worse. As more than 230 million Asian individuals are living with diabetes that may lead to rising diabetes wound drives wound cleanser market in this region. Such factors allow infection control education among healthcare professionals.
For instance, HCAH partnered with Aroa Biosurgery in September 2024 to enhance wound care, focusing on complex vascular and diabetic wounds. The initiative introduces the "WOW Nurses" program, aimed at preventing and treating bedsores. This program emphasizes specialized training for nurses to improve patient recovery, reduce complications, and promote faster healing outcomes.
Second, some 51.4 million inpatient surgeries annually account for more than 400,000 additional days spent in the hospital along with an added healthcare bill of almost US$900 million further, SSIs affect increasing numbers of chronic wounds and the rising prevalence of both requires improving their management and developing economical methods. Such factors lead to rising demand for wound care in this region.
In Europe, HAIs affect about 9 million HAIs occur every year in acute and long-term care facilities which lead to 25 million extra hospital days and cost EUR 13-24 billion. In Europe, effective wound care plays a crucial role in preventing HAIs, by ensuring proper wound cleansing, dressing, and management, healthcare providers minimize infection risks, promote faster healing, and reduce complications. For this reason, the government is focusing on the emphasis of wound care in this region.
For example, the UK’s 2024 Wound Care Initiative targets the increasing challenge of chronic wounds, which expense the NHS GBP 8.3 billion each year. Drawing from past achievements, the program aims to transform wound care by encouraging collaboration with healthcare leaders to boost integration and emphasize efficient care, thereby improving the quality and accessibility of treatment for patients with chronic wounds. Progressive wound care methods, including antimicrobial therapies and cutting-edge dressings, are essential for protecting patient results and lowering healthcare expenses.
The Asia-Pacific region is expected to grow at the fastest rate due to the prevalence of chronic diseases, particularly in countries like China, India, and Japan which leads to healthcare awareness and improvements healthcare system. In nations such as India, the problem is worsened by restricted healthcare availability, poor levels of education, and financial obstacles, which lead to delays in treatment and make wound care issues worse. As more than 230 million Asian individuals are living with diabetes that may lead to rising diabetes wound drives wound cleanser market in this region. Such factors allow infection control education among healthcare professionals.
For instance, HCAH partnered with Aroa Biosurgery in September 2024 to enhance wound care, focusing on complex vascular and diabetic wounds. The initiative introduces the "WOW Nurses" program, aimed at preventing and treating bedsores. This program emphasizes specialized training for nurses to improve patient recovery, reduce complications, and promote faster healing outcomes.
Searching for a Country or Region-Specific Report?
Unlock industry complexities with reports crafted for selected countries and regions at Reduced Cost
The report provides a detailed overview of the wound cleanser market insights in regions including North America, Latin America, Europe, Asia-Pacific and the Middle East and Africa. The country-specific assessment for wound cleanser market has been offered for all regional market share, along with forecasts, market scope estimates, price point assessment, and impact analysis of prominent countries and regions. Throughout this market research report, Y-o-Y growth and CAGR estimates are also incorporated for every country and region, to provide a detailed view of the wound cleanser market. These Y-o-Y projections on regional and country-level markets brighten the political, economic and business environment outlook, which are anticipated to have a substantial impact on the growth of the wound cleanser market. Some key country and region included in the wound cleanser market report as follows:
| Regions | Countries |
|---|---|
| North America | United States, Canada |
| Latin America | Brazil, Mexico, Argentina, Colombia, Chile, Rest of Latin America |
| Europe | Germany, United Kingdom, France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Norway, Denmark, Finland, Ireland, Czech Republic, Rest of Europe |
| Asia Pacific | China, India, Japan, South Korea, Australia & New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia Pacific |
| Middle East and Africa | GCC Countries, South Africa, Egypt, Turkey, Morocco, Israel, Iran, Kenya, Nigeria, Rest of MEA |
Wound Cleanser Market Research Report Covers In-depth Analysis on:
- Wound cleanser market detailed segments and segment-wise market breakdown
- Wound cleanser market dynamics (Recent industry trends, drivers, restraints, growth potential, opportunities in wound cleanser industry)
- Current, historical and forthcoming 10 years market valuation in terms of wound cleanser market size (US$ Mn), volume (Units), share (%), Y-o-Y growth rate, CAGR (%) analysis
- Wound cleanser market demand analysis
- Wound cleanser market pricing analysis over forecast period (by key segment and by region)
- Wound cleanser market regional insights with region-wise market breakdown
- Competitive analysis – key companies profiling including their market share, product offerings, and competitive strategies.
- Latest developments and innovations in wound cleanser market
- Regulatory landscape by key regions and key countries
- Supply chain and value chain analysis in wound cleanser market
- Wound cleanser market sales and distribution strategies
- A comprehensive overview of parent market
- A detailed viewpoint on wound cleanser market forecast by countries
- Mergers and acquisitions in wound cleanser market
- Essential information to enhance market position
- Robust research methodology
- Frequently Asked Questions -
What factors are driving the growth of the wound cleanser market?
The growth is driven by the increasing prevalence of chronic wounds, rising awareness of wound care, and the development of advanced, non-toxic wound cleaning products for better patient outcomes.
What are the key trends in the wound cleanser market?
Key trends include the shift toward natural and biodegradable ingredients in wound care products and the growing demand for non-invasive treatments to minimize infection and accelerate healing.
What challenges are faced by the wound cleanser market?
The market faces challenges such as high costs of advanced wound care products, regulatory constraints, and the difficulty of standardizing wound cleansing procedures across diverse medical environments.
